Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-28 @ 4:55 AM
Study NCT ID:
NCT04806503
Status:
TERMINATED
Last Update Posted:
2024-06-20
First Post:
2021-03-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-14
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-16
First Submit QC Date:
None
Study First Post Date:
2021-03-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-07-14
Results First Submit QC Date:
None
Results First Post Date:
2023-08-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-08-30
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-06-17
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL